NIH-funded research R15 grant

Understanding how certain enzymes affect cytomegalovirus infection

Official title: Role of Deubiquitinases in CMV Pathogenesis

Funded at Auburn University at Auburn · NIH-10730892 · Data updated 2026-11-12

This study is looking at how certain enzymes help the cytomegalovirus (CMV) avoid the immune system, which could lead to new treatments for people affected by this virus.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionAuburn University at Auburn
NIH-funded
Lab location1 site (Auburn, UNITED STATES)
Project startJuly 5, 2023
Project endJune 30, 2026
Funding year2023
Award (this year)$456,008
NIH project number1R15AI171796-01A1
Project IDNIH-10730892 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research are adults over 21 years old who are infected with cytomegalovirus or at risk of infection.

Less likely to help

Patients who are not infected with cytomegalovirus or do not have a risk of infection may not receive any benefit from this research.

What this research studies

This research investigates the role of deubiquitinases, which are enzymes that remove ubiquitin from proteins, in the infection process of cytomegalovirus (CMV). By studying how these enzymes influence the virus's ability to cause disease, the research aims to uncover the molecular mechanisms that allow CMV to evade the immune response. The approach involves examining the interactions between viral and host proteins during natural infections, which could lead to new insights into antiviral strategies. Patients may benefit from this research as it could inform the development of targeted antiviral therapies.

Why it matters

Potential benefit: If successful, this research could lead to new antiviral treatments that improve outcomes for patients infected with cytomegalovirus.

How similar studies have gone: Previous research has shown that targeting viral deubiquitinases can be effective in controlling viral infections, suggesting that this approach may yield promising results.

Where this research is happening

  • Auburn University at Auburn
    Auburn, United States
    Active

Researchers

  • Principal investigator: Upton, Jason W — Auburn University at Auburn
  • Study coordinator: Upton, Jason W

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.